Moat Ross
CHIEF OPERATING OFFICER
Moat Ross has filed 6 SEC Form 4 filings (19 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Sep 3, 2026.
On the most recent filing, Moat Ross is listed as CHIEF OPERATING OFFICER at Kiniksa Pharmaceuticals International, plc. Inside the rolling window, Moat Ross reported no open-market purchases and 2 open-market sales totaling $195K in KNSA. The largest disclosed transaction in the window is a sale of 2,367 KNSA shares on Apr 6, 2026, worth $115K.
Companies traded
Other insiders at KNSA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$195K
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 4, 2025 | KNSA | Sale | $124K |
Frequently asked questions
How many SEC Form 4 filings has Moat Ross made?
Moat Ross has filed 6 SEC Form 4 filings (19 transaction rows) across 1 company since 2025.
Which companies does Moat Ross trade?
Moat Ross has filed SEC Form 4 disclosures for 1 company, including KNSA.
When was Moat Ross's most recent SEC Form 4 filing?
Moat Ross's most recent SEC Form 4 filing on Tracefour is dated Sep 3, 2026.
What is Moat Ross's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Moat Ross is listed as CHIEF OPERATING OFFICER.
What is Moat Ross's total buy and sell value in the current window?
Inside the rolling retention window, Moat Ross bought $0 and sold $195K based on SEC Form 4 filings.
What was Moat Ross's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 2,367 KNSA shares on 2026-04-06, worth $115K, per SEC Form 4 filings.